← All companies

TWST

Twist Bioscience Corporation

TWST Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$101.06

+9.73 +10.65%

Key statistics

from XBRL data in SEC filings

Market cap

$6.34B

Revenue (TTM)

$432M

Net income (TTM)

-$137M

EPS (TTM)

$-2.21

P/E ratio

—

Dividend yield

—

Free cash flow

-$75.6M

Cash

$117M

Total assets

$672M

Gross margin

—

52-week range

$23.30 – $105.47

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) May 4, 2026 10-Q/A Quarter ended 2025-12-31 Feb 26, 2026 8-K Unregistered sale of equity; Other events Feb 17, 2026 8-K Shareholder vote results Feb 6, 2026 10-Q Quarter ended 2025-12-31 Feb 2, 2026 8-K Results of operations (earnings release) Feb 2, 2026 8-K Results of operations (earnings release) Jan 12, 2026 10-K Fiscal year ended 2025-09-30 Nov 17, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Director or officer change Aug 6, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release) Aug 4, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure May 5, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Feb 11, 2025 10-Q Quarter ended 2024-12-31 Feb 3, 2025 8-K Results of operations (earnings release) Feb 3, 2025 10-K Fiscal year ended 2024-09-30 Nov 18, 2024 8-K Results of operations (earnings release) Nov 18, 2024 8-K Director or officer change Oct 15, 2024 10-Q Quarter ended 2024-06-30 Aug 2, 2024 8-K Results of operations (earnings release) Aug 2, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Shareholder vote results Feb 7, 2024 10-Q Quarter ended 2023-12-31 Feb 2, 2024 8-K Results of operations (earnings release) Feb 2, 2024 8-K Director or officer change; Regulation FD disclosure Jan 5, 2024 10-K Fiscal year ended 2023-09-30 Nov 21, 2023 8-K Results of operations (earnings release) Nov 17, 2023 10-Q Quarter ended 2023-06-30 Aug 7, 2023 8-K Results of operations (earnings release); Director or officer change Aug 4, 2023 8-K/A Exit or disposal costs Aug 4, 2023 10-K/A Fiscal year ended 2022-09-30 Jun 5, 2023 8-K Director or officer change May 23, 2023 10-Q Quarter ended 2023-03-31 May 8, 2023 8-K Results of operations (earnings release); Exit or disposal costs May 5, 2023